Development and validation of a new radiographic scoring system to evaluate bone and cartilage destruction and healing of large joints with rheumatoid arthritis: ARASHI (Assessment of rheumatoid arthritis by scoring of large joint destruction and healing in radiographic imaging) study

References

• Gardner DL: Rheumatoid arthritis: cell and tissue pathology. In: Pathological basis of the connective tissue diseases. London: Edward Arnold; 1992: 444–526.
   Google Scholar
• Pappas, DA: Treatment of rheumatoid arthritis: tumor necrosis factor inhibitors. In: Hochberg MC, Silman A, Smolen JS, Weinblat ME, Weisman MH, editors. Rheumatoid arthritis. Philadelphia: Mosby, an affiliate of Elsevier; 2009: 337–349.
   Google Scholar
• Mount C, Featherstone J. Rheumatoid arthritis market. Nat Rev Drug Discov. 2005; 4(1): 11–12.
   PubMedGoogle Scholar
• Klareskog L, Heijde D, Jager JP, Gough A, Kalden J, Malaise M, Martin Mola E, Pavelka K, Sany J, Settas L, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet. 2004; 363(9410): 675–681.
   PubMed Web of Science ®Google Scholar
• Heijde D, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J, Tornero-Molina J, Wajdula J, Pedersen R, Fatenejad S. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum. 2006; 54(4): 1063–1074.
   PubMedGoogle Scholar
• Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 2006; 54(1): 26–37.
   PubMed Web of Science ®Google Scholar
• Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Murata N, Heijde D, Kishimoto T. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis. 2007; 66(9): 1162–1167.
   PubMed Web of Science ®Google Scholar
• Kooij SM, Cessie S, Goekoop-Ruiterman YP, Vries-Bouwstra JK, Zeben D, Kerstens PJ, Hazes JM, Schaardenburg D, Breedveld FC, Dijkmans BA, et al. Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Ann Rheum Dis. 2009; 68(7): 1153–1158.
   PubMedGoogle Scholar
• Emery P, Durez P, Dougados M, Legerton CW, Becker JC, Vratsanos G, Genant HK, Peterfy C, Mitra P, Overfield S, et al. Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial). Ann Rheum Dis. 2009; 69(3): 510–516.
   PubMedGoogle Scholar
• Lipsky PE, Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. New Eng J Med. 2000; 343(22): 1594–1602.
   PubMed Web of Science ®Google Scholar
• Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, Decker JL, Genant HK, Gofton JP, Goodman N, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?. Arthritis Rheum. 1985; 28(12): 1326–1335.
   PubMedGoogle Scholar
• Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol. 1999; 26(3): 743–745.
   PubMedGoogle Scholar
• Heijde D, Dankert T, Nieman F, Rau R, Boers M. Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology (Oxford). 1999; 38(10): 941–947.
   PubMedGoogle Scholar
• Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A. A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol. 1998; 25(11): 2094–2107.
   PubMedGoogle Scholar
• Genant HK: Methods of assessing radiographic change in rheumatoid arthritis. Am J Med. 1983;75(6A):35–47.
   Google Scholar
• Scott DL, Houssien DA, Laasonen L. Proposed modification to Larsen’s scoring methods for hand and wrist radiographs. Br J Rheumatol. 1995; 34(1): 56
   PubMedGoogle Scholar
• Harris ED, Jr.: Clinical features of rheumatoid arthritis. In: Kelley WN, Harris ED, Jr., Ruddy S, Seledge CB, editors. Kelly’s textbook of rheumatology, 4th edn. Philadelphia: W.B. Saunders Company; 1993. p. 874–911. vol. 1.
   Google Scholar
• Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiologica: Diagnosis. 1977; 18(4): 481–491.
   PubMedGoogle Scholar
• Larsen A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol. 1995; 22(10): 1974–1975.
   PubMed Web of Science ®Google Scholar
• Boini S, Guillemin F. Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. Ann Rheum Dis. 2001; 60(9): 817–827.
   PubMedGoogle Scholar
• Pincus T, Fuchs HA, Callahan LF, Nance EP Jr, Kaye JJ. Early radiographic joint space narrowing and erosion and later malalignment in rheumatoid arthritis: a longitudinal analysis. J Rheumatol. 1998; 25(4): 636–640.
   PubMed Web of Science ®Google Scholar
• Kovacs FM, Abraira V, Royuela A, Corcoll J, Alegre L, Tomas M, Mir MA, Cano A, Muriel A, Zamora J, et al. Minimum detectable and minimal clinically important changes for pain in patients with nonspecific neck pain. BMC Musculoskelet Disord. 2008; 943
   PubMed Web of Science ®Google Scholar
• Haley SM, Fragala-Pinkham MA. Interpreting change scores of tests and measures used in physical therapy. Phys Ther. 2006; 86(5): 735–743.
   PubMedGoogle Scholar
• Rau R, Wassenberg S, Herborn G, Perschel WT, Freitag G. Identification of radiologic healing phenomena in patients with rheumatoid arthritis. J Rheumatol. 2001; 28(12): 2608–2615.
   PubMedGoogle Scholar
• Rau R: Is remission in rheumatoid arthritis associated with radiographic healing? Clin Exp Rheumatol. 2006; 24(6 Suppl 43):S-41–S-44.
   Google Scholar
• Wassenberg S, Rau R. Radiographic healing with sustained clinical remission in a patient with rheumatoid arthritis receiving methotrexate monotherapy. Arthritis Rheum. 2002; 46(10): 2804–2807.
   PubMedGoogle Scholar
• Sokka T, Hannonen P. Healing of erosions in rheumatoid arthritis. Ann Rheum Dis. 2000; 59(8): 647–649.
   PubMedGoogle Scholar
• Schett G, Stach C, Zwerina J, Voll R, Manger B. How antirheumatic drugs protect joints from damage in rheumatoid arthritis. Arthritis Rheum. 2008; 58(10): 2936–2948.
   PubMedGoogle Scholar
• Tanaka E, Saito A, Kamitsuji S, Yamada T, Nakajima A, Taniguchi A, Hara M, Tomatsu T, Yamanaka H, Kamatani N. Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology Core Data Set. Arthritis Rheum. 2005; 53(6): 864–871.
   PubMedGoogle Scholar
• Momohara S, Tanaka E, Iwamoto T, Ikari K, Yamanaka H. Reparative radiological changes of a large joint after adalimumab for rheumatoid arthritis. Clin Rheumatol. 2011; 30(4): 591–592.
   PubMedGoogle Scholar
• Ozaki T, Hashizume K, Nakahara R, Nishida K: Radiographic remodeling of the shoulder joint in a patient with rheumatoid arthritis after 4 years of treatment with etanercept. Modern rheumatology/the Japan Rheumatism Association 2012.
   Google Scholar
• Seki E, Matsushita I, Sugiyama E, Taki H, Shinoda K, Hounoki H, Motomura H, Kimura T. Radiographic progression in weight-bearing joints of patients with rheumatoid arthritis after TNF-blocking therapies. Clin Rheumatol. 2009; 28(4): 453–460.
   PubMed Web of Science ®Google Scholar
• Heijde DM. Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. Bailliere’s Clin Rheumatol. 1996; 10(3): 435–453.
   PubMedGoogle Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Guidance for industry clinical development programs for drugs, devices, and biological products for the treatment of rheumatoid arthritis (RA). Silver Spring, MD, USA; 1999.
   Google Scholar
• Ostergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, Shnier R, O’Connor P, Klarlund M, Emery P, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol. 2003; 30(6): 1385–1386.
   PubMedGoogle Scholar
• Bruynesteyn K, Heijde D, Boers M, Lassere M, Boonen A, Edmonds J, Houben H, Paulus H, Peloso P, Saudan A, et al. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts. J Rheumatol. 2001; 28(4): 904–910.
   PubMedGoogle Scholar